Uzma Ahmed

Uzma Ahmed, MD, MS, currently serves as the Director Clinical Scientist at Celcuity, focusing on Phase I-III solid tumors clinical trials. Prior to this role, Uzma worked as the Director Clinical Development Scientist at Biomea Fusion, specializing in covalent menin inhibitors for various solid tumors and hematological malignancies, and was involved in critical clinical monitoring activities. Uzma's previous experience also includes roles as Director at Gritstone Bio, Clinical Development Scientist at Takeda, and Director of Clinical Science at Iovance Biotherapeutics, where responsibilities encompassed data review for registrational studies and clinical development planning. Earlier in the career, Uzma held positions at Gilead Sciences, Stanford University School of Medicine as Clinical Research Coordinator, and Veterans Health Administration as Health Science Specialist, contributing to various clinical research and operational roles in oncology and mental health. Uzma Ahmed holds an MS in Health Care Administration from California State University - East Bay and an MD from Jinnah Sindh Medical University.